• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺钼靶筛查结果的分类——一种减轻召回焦虑的方法?

Classification of findings in mammography screening--a method to minimise recall anxiety?

作者信息

Pamilo M, Lönnqvist J, Halttunen A, Soiva M, Suramo I

机构信息

Mammography Screening Centre, Cancer Society of Finland, Helsinki.

出版信息

J Epidemiol Community Health. 1991 Dec;45(4):321-4. doi: 10.1136/jech.45.4.321.

DOI:10.1136/jech.45.4.321
PMID:1795155
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1059470/
Abstract

STUDY OBJECTIVE

The aim was to find out if it is possible, by classifying screening mammograms according to the likelihood of malignancy, to divide the recalled women to a group in which there is high suspicion of malignancy, most having breast cancers, and a group with more obscure findings.

DESIGN

Screening mammograms of recalled women were classified according to the likelihood of malignancy. 0 = technically insufficient, 1 = normal, 2 = benign tumour, 3 = malignancy cannot be excluded, 4 = strongly suspicious for malignancy, 5 = malignant.

SETTING

This study was a population based survey of mammography screening in Helsinki and surroundings in Finland.

PATIENTS

21,417 women (aged 50-59 years) were invited to be screened, 18,012 (84.10%) participated. Of these 579 (3.21% of those screened) were recalled for further studies; 124 of these were referred for surgical biopsy and 82 had breast cancer.

MEASUREMENTS AND MAIN RESULTS

All cases classified as 5, 60% of the cases classified as 4, 6.5% of the cases classified as 3, 0% of the cases classified as 2 or 1, and 1.2% of the cases classified as 0 proved to have breast cancers. However classification 5 represented 5.9% of all recalled women and 41.5% of all screening detected breast cancers; classification 4, 6.0% of all recalled women and 25.6% of all screening detected breast cancers; classification 3, 68.9% of all recalled women and 31.7% of all screening detected breast cancers; classification 2, 11.7% and classification 1, 2.9% of all recalled women. No breast cancers were detected with these classifications. Classification 0 represented 4.5% of all recalled women and 1.2% of all screening detected breast cancers. Classifications 5 and 4 represented only 11.9% of all recalled women but 67.1% of all screening detected breast cancers.

CONCLUSIONS

By classifying screening mammograms according to the likelihood of malignancy, recalled women can be divided into two groups: (1) a quite small subgroup in which everyone or almost everyone will be shown to have breast cancer; and (2) a much larger subgroup in which only a few will be proven to have breast cancer. The invitation procedure for the further studies should be improved on this basis of minimising anxiety among recalled women.

摘要

研究目的

旨在查明是否有可能通过根据恶性可能性对乳腺钼靶筛查图像进行分类,将召回的女性分为两组,一组是高度怀疑恶性、多数患有乳腺癌的女性,另一组是检查结果较为模糊的女性。

设计

根据恶性可能性对召回女性的乳腺钼靶筛查图像进行分类。0 = 技术上不充分,1 = 正常,2 = 良性肿瘤,3 = 不能排除恶性,4 = 高度怀疑恶性,5 = 恶性。

研究背景

本研究是一项基于芬兰赫尔辛基及周边地区乳腺钼靶筛查的人群调查。

研究对象

邀请了21417名年龄在50至59岁之间的女性进行筛查,其中18012名(84.10%)参与。在这些参与者中,579名(占筛查人数的3.21%)被召回进一步检查;其中124名被转诊进行手术活检,82名患有乳腺癌。

测量指标与主要结果

所有分类为5的病例、60%分类为4的病例、6.5%分类为3的病例、0%分类为2或1的病例以及1.2%分类为0的病例被证实患有乳腺癌。然而,分类为5的病例占所有召回女性的5.9%,占所有筛查发现乳腺癌的41.5%;分类为4的病例占所有召回女性的6.0%,占所有筛查发现乳腺癌的25.6%;分类为3的病例占所有召回女性的68.9%,占所有筛查发现乳腺癌的31.7%;分类为2的病例占所有召回女性的11.7%,分类为1的病例占所有召回女性的2.9%。这些分类中未检测到乳腺癌。分类为0的病例占所有召回女性的4.5%,占所有筛查发现乳腺癌的1.2%。分类为5和4的病例仅占所有召回女性的11.9%,但占所有筛查发现乳腺癌的67.1%。

结论

通过根据恶性可能性对乳腺钼靶筛查图像进行分类,召回的女性可以分为两组:(1)一个非常小的亚组,其中每个人或几乎每个人都将被证明患有乳腺癌;(2)一个大得多的亚组,其中只有少数人将被证明患有乳腺癌。应在此基础上改进进一步检查的邀请程序,以尽量减少召回女性的焦虑。

相似文献

1
Classification of findings in mammography screening--a method to minimise recall anxiety?乳腺钼靶筛查结果的分类——一种减轻召回焦虑的方法?
J Epidemiol Community Health. 1991 Dec;45(4):321-4. doi: 10.1136/jech.45.4.321.
2
Mammography screening for breast cancer: first year results from Helsinki and surroundings.乳腺癌的乳腺钼靶筛查:赫尔辛基及其周边地区的第一年结果。
Ann Med. 1989 Aug;21(4):277-9. doi: 10.3109/07853898909149206.
3
Delayed diagnosis of breast cancer in women recalled for suspicious screening mammography.因乳腺钼靶筛查结果可疑而被召回的女性乳腺癌延迟诊断。
Eur J Cancer. 2009 Mar;45(5):774-81. doi: 10.1016/j.ejca.2008.10.020. Epub 2008 Dec 4.
4
Frequency and characteristics of additionally detected ipsilateral breast lesions following recall at screening mammography.筛查性乳房 X 光摄影时召回后额外检测到的同侧乳房病变的频率和特征。
Breast. 2018 Dec;42:94-101. doi: 10.1016/j.breast.2018.08.104. Epub 2018 Aug 28.
5
Short- and long-term anxiety and depression in women recalled after breast cancer screening.
Eur J Cancer. 2001 Mar;37(4):463-9. doi: 10.1016/s0959-8049(00)00426-3.
6
Minority report - false negative breast assessment in women recalled for suspicious screening mammography: imaging and pathological features, and associated delay in diagnosis.少数病例报告——因乳腺钼靶筛查可疑而被召回的女性中乳腺评估假阴性:影像学和病理特征以及相关诊断延迟
Breast Cancer Res Treat. 2007 Sep;105(1):37-43. doi: 10.1007/s10549-006-9425-3. Epub 2006 Nov 18.
7
Screening mammography in Finland--1.5 million examinations with 97 percent specificity. Mammography Working Group, Radiological Society of Finland.芬兰的乳腺钼靶筛查——150万次检查,特异性达97%。芬兰放射学会乳腺钼靶工作组
Acta Oncol. 1999;38 Suppl 13:47-54. doi: 10.1080/028418699432761.
8
Frequency and characteristics of contralateral breast abnormalities following recall at screening mammography.筛查性乳房 X 光摄影检查后召回时对侧乳腺异常的频率和特征。
Eur Radiol. 2018 Oct;28(10):4205-4214. doi: 10.1007/s00330-018-5370-x. Epub 2018 Apr 17.
9
Mammography screening--reasons for recall and the influence of experience on recall in the Finnish system.
Clin Radiol. 1990 Jun;41(6):384-7. doi: 10.1016/s0009-9260(05)80596-3.
10
Mammographic findings of women recalled for diagnostic work-up in digital versus screen-film mammography in a population-based screening program.在一项基于人群的筛查项目中,因诊断性检查而被召回的女性在数字化乳腺钼靶与屏-片乳腺钼靶检查中的乳腺钼靶检查结果。
Acta Radiol. 2010 Jun;51(5):491-7. doi: 10.3109/02841851003691961.

本文引用的文献

1
Screening for breast cancer: the Swedish trial.
Radiology. 1981 Jan;138(1):219-22. doi: 10.1148/radiology.138.1.7005939.
2
Women who decline breast screening.拒绝乳腺筛查的女性。
J Epidemiol Community Health. 1984 Dec;38(4):278-83. doi: 10.1136/jech.38.4.278.
3
Evaluation of screening for breast cancer in a non-randomised study (the DOM project) by means of a case-control study.通过病例对照研究对一项非随机研究(DOM项目)中的乳腺癌筛查进行评估。
Lancet. 1984 Jun 2;1(8388):1224-6. doi: 10.1016/s0140-6736(84)91704-5.
4
Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen project, 1975-1981.通过现代乳腺钼靶摄影进行大规模筛查降低乳腺癌死亡率。奈梅亨项目的初步结果,1975 - 1981年
Lancet. 1984 Jun 2;1(8388):1222-4. doi: 10.1016/s0140-6736(84)91703-3.
5
Breast cancer screening: a different look at the evidence.乳腺癌筛查:对证据的不同审视。
Surgery. 1986 Oct;100(4):594-8.
6
Psychiatric morbidity after screening for breast cancer.乳腺癌筛查后的精神疾病发病率
J Epidemiol Community Health. 1986 Mar;40(1):71-5. doi: 10.1136/jech.40.1.71.
7
Breast cancer risk for women with a false positive screening test.筛查试验结果为假阳性的女性患乳腺癌的风险。
Br J Cancer. 1988 Aug;58(2):211-2. doi: 10.1038/bjc.1988.195.
8
Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial.乳腺钼靶筛查与乳腺癌死亡率:马尔默乳腺钼靶筛查试验
BMJ. 1988 Oct 15;297(6654):943-8. doi: 10.1136/bmj.297.6654.943.
9
A licence for breast cancer screening?乳腺癌筛查许可证?
Br Med J (Clin Res Ed). 1988 Mar 26;296(6626):909-11. doi: 10.1136/bmj.296.6626.909.
10
A case-control study of the efficacy of a non-randomized breast cancer screening program in Florence (Italy).意大利佛罗伦萨一项关于非随机乳腺癌筛查项目疗效的病例对照研究。
Int J Cancer. 1986 Oct 15;38(4):501-4. doi: 10.1002/ijc.2910380408.